Nasdaq: NBIX
Neurocrine Biosciences insiders
The officers, directors and 10% owners of Neurocrine Biosciences, Inc. who hold the most stock, valued at the live NBIX price.
$156.59
NBIX today −$6.3M (−3.85%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 13
- Their NBIX stock
- $182M
- Market value
- $15.85B
- Held by ranked insiders
- 1.15%
Insiders by value of NBIX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Kevin Charles Gorman | Director | 517,797 | $81.1M | 0.51% | 1758th |
| 2 | Kyle Gano | Chief Executive Officer | 155,010 | $24.3M | 0.15% | 4475th |
| 3 | Gary A. Lyons | Director | 122,141 | $19.1M | 0.12% | 4752nd |
| 4 | Eric Benevich | Chief Commercial Officer | 67,297 | $10.5M | <0.1% | 8450th |
| 5 | Darin Lippoldt | Chief Legal Officer | 56,793 | $8.9M | <0.1% | 9599th |
| 6 | Eiry Roberts | Chief Medical Officer | 51,331 | $8.0M | <0.1% | 9979th |
| 7 | William H. Rastetter | Director | 43,678 | $6.8M | <0.1% | 8559th |
| 8 | Matt Abernethy | Chief Financial Officer | 42,808 | $6.7M | <0.1% | 11766th |
| 9 | Malcolm Lloyd-Smith | Chief Integration Officer | 42,337 | $6.6M | <0.1% | 11860th |
| 10 | Richard F. Pops | Director | 37,798 | $5.9M | <0.1% | 1997th |
| 11 | Stephen A. Sherwin | Director | 14,860 | $2.3M | <0.1% | 12656th |
| 12 | Johanna Mercier | Director | 6,853 | $1.1M | <0.1% | 5303rd |
| 13 | Christine A. Poon | Director | 4,753 | $744K | <0.1% | 7643rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Neurocrine Biosciences; see each profile for the filing.